Buy the Dip in Semiconductor Stocks & ETFs?

Semiconductor demand and investment forecasts remain strong despite a sharp pullback: SOXX fell about 12% over five sessions through Oct. 15, 2026, but is still up roughly 60% year to date. Gartner forecasts global chip revenue of $1.6 trillion in 2026 and $1.94 trillion in 2027; McKinsey estimates five hyperscalers plan about $1 trillion in 2027 capex, mostly for AI infrastructure. Micron has 26 long-term customer agreements covering approximately 35% of revenue through 2030, while Broadcom forecasts AI-chip revenue of about $115 billion in fiscal 2027 and $230 billion in fiscal 2028; rising rates and oil prices remain risks to valuations.

Analysis

The key distinction is between demand visibility and realized returns on AI infrastructure. Long-dated customer agreements and tool-order interest can support planning, but neither proves take-or-pay revenue or that hyperscaler spending will earn adequate returns. If AI utilization disappoints, capex can be cut before the semiconductor supply chain has time to adjust; that would hit high-expectation AI and memory exposures disproportionately. Conversely, constrained HBM supply can support pricing near term while encouraging customers to qualify alternatives and suppliers to add capacity, making today’s pricing strength vulnerable over a 6–18 month horizon.

Prefer selective exposure over buying the whole sector after a large year-to-date advance. MU has the clearest stated revenue visibility, but memory remains cyclical: verify contract duration, pricing clauses, and whether supply tightness is translating into realized margins. ASML’s extended customer planning supports equipment demand with a longer lead time, but order interest is not booked revenue, and export restrictions or delayed fab plans could reverse the signal. AVGO’s ambitious AI revenue trajectory is a high bar; a miss or capex digestion could drive multiple compression. The article’s ETF P/E comparison is not sufficient to establish relative value: trailing earnings and portfolio composition may differ, and a lower multiple does not establish a cheaper AI exposure.

Near term, rates and oil-driven inflation can overwhelm earnings revisions and sustain multiple pressure. The contrarian opportunity is to accumulate only after price stabilization, not to infer a durable floor from the selloff. The thesis weakens if hyperscalers reduce capex plans, MU’s pricing or margin outlook rolls over, or ASML orders convert into cancellations or deferrals.

Key Decisions for Investors

• Stage a long MU position on stabilization rather than chasing a rebound; keep sizing modest until the next results confirm that HBM pricing and customer agreements are supporting realized revenue and margins. Reassess on any guidance reduction or evidence that memory supply is catching up.
• Prefer ASML as a longer-horizon, staged exposure to continued fab investment, but treat customer interest extending into 2029–30 as an early indicator, not secured sales. Track order intake, cancellations, capacity commitments, and export-control developments before adding.
• Avoid an indiscriminate SOXX/SMH dip-buy for now. If adding sector beta, scale in over several weeks and hedge part of the exposure with SOXX puts or reduced gross if rates and oil continue higher; the recent drawdown may persist despite intact long-term demand.
• Use hyperscaler capex revisions and AI workload utilization as the key 1–3 month checks. A meaningful downgrade to spending plans, weaker MU pricing/margins, or ASML order deferrals would falsify the demand thesis and warrant reducing exposure; confirmation without improving share-price breadth would argue the rebound is not yet established.